ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT00006369
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
ERA-923
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
[object Object]